Skip to content

A clinical trial to study the effects in Sleeve Gastrectomy Patients in Morbid Obesity and related Diseases.

A Randomised study of LinEar Staple Line Reinforcement in Sleeve Gastrectomy Patients using Peristrips Dry with Veritas Collagen Matrix . - SEAL

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/05/001717
Enrollment
100
Registered
2011-05-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Morbid obesity and related diseases.

Interventions

Intervention1: Intervention and comparator agent CONTROL ARM VERSUS PSDV ARM.: Intervention and comparator agent. In CONTROL ARM PSDV product will not be used, while in PSDV ARM, PSDV product will be

Sponsors

Synovis Surgical Innovations
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Adult males or females with a age between 18-75 yrs. 2.subject /LAR must be able to give written informed consent form. 3 Must have a BMI 32.5kg/m2 with one or more co morbidities or BMI 37.5kg/m2. 4. Must be willing and able to return for follow up visits. 5 Subject should be a good candidate for sleeve Gastrectomy.

Exclusion criteria

Exclusion criteria: 1.Subject must not have previous or known allergy or sensitivity to bovine products. 2. No previous abdominal history that could affect the outcome of the trial. 3. Uncontrolled Hypertension.

Design outcomes

Primary

MeasureTime frame
To evaluate the staple line bleeds and staple line leaks associated with the use of PSDV as staple line reinforcement during LSG surgery versus a control group.Timepoint: 18 months

Secondary

MeasureTime frame
To evaluate the Operating room time and the number of clips and or sutures used to control bleeding in the PSDV group versus the control group.Timepoint: 18 months.

Countries

India

Contacts

Public ContactDr Jayashree Todkar

consulting laparoscopic and bariatric surgeon

drshashanks@gmail.com91-9822026734

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026